PRDX1 and colitis: Compared with control IgG, the Prdx1-neutralizing antibody significantly alleviated DSS-induced colitis in WT mice, as indicated by increased body weight (Fig. 4B) and decreased disease activity (Fig. 4C), which were accompanied by decreased histopathological scores (Fig. 4D).